```html

Nipple Discharge (Galactorrhea) – A Patient‑Friendly Guide

Overview

Galactorrhea is the spontaneous flow of milk or a milky‑colored fluid from one or both nipples unrelated to normal lactation. It can affect people of any age, sex, and hormonal status, although it is most commonly reported in women of reproductive age and in men taking certain medications.

• Prevalence: Studies estimate that up to 2–4 % of women and 1 % of men will experience some form of nipple discharge in their lifetime.
• Typical age: 20–45 years for women; 30–60 years for men, largely due to medication use.

Most cases are benign, but because discharge can sometimes signal an underlying endocrine disorder, pituitary tumor, or breast pathology, proper evaluation is essential.

Symptoms

The presentation can vary widely. Common symptoms include:

• Milky, white, or yellowish fluid: The classic “milk‑like” appearance, but secretions can also be clear, green, brown, or bloody.
• Unilateral vs. bilateral discharge: Both nipples may be involved (bilateral) or only one (unilateral). Bilateral discharge is more often linked to hormonal causes.
• Frequency: May be constant, intermittent, or only when the nipple is stimulated.
• Associated breast changes: Lump, tenderness, or skin changes may accompany discharge.
• Menstrual irregularities: Oligomenorrhea, amenorrhea, or infertility in women, suggesting hormonal imbalance.
• Headache or visual disturbances: May point to a pituitary adenoma.
• Sexual side effects: Decreased libido or erectile dysfunction in men.
• Systemic symptoms: Unexplained weight gain, fatigue, or hot flashes, often related to prolactin excess.

Causes and Risk Factors

Hormonal Imbalance (Hyperprolactinemia)

Elevated prolactin is the most frequent cause. Prolactin stimulates milk production, and its excess can result from:

• Pituitary adenomas (prolactinomas) – Mayo Clinic cites a prevalence of 0.1 % in the general population.
• Hypothyroidism – low thyroid hormone removes inhibition on prolactin release.
• Chest wall irritation (e.g., tight bras, shingles, breast trauma).

Medications

Drugs that increase dopamine blockade or affect serotonin can raise prolactin levels:

• Antipsychotics (risperidone, haloperidol, olanzapine).
• Antidepressants (SSRIs, tricyclics).
• Antiemetics (metoclopramide, domperidone).
• Blood pressure agents (verapamil, methyldopa).

Physiological Causes

• Pregnancy and postpartum lactation – normal and self‑limiting.
• Breast stimulation (frequent nursing, sexual activity, vigorous exercise).

Other Pathologies

• Breast infections (mastitis) or abscesses.
• Ductal ectasia – dilation of milk ducts, more common after menopause.
• Intraductal papilloma – benign tumor that may produce bloody discharge.
• Rare malignancies (ductal carcinoma in situ, infiltrating carcinoma).

Risk Factors

• Female sex, especially during reproductive years.
• Use of prolactin‑raising medications.
• Thyroid disease or pituitary disorders.
• Obesity – adipose tissue can increase estrogen, indirectly influencing prolactin.
• Stress – acute stress can transiently boost prolactin.

Diagnosis

Evaluation aims to identify the underlying cause and rule out serious disease.

Clinical History & Physical Exam

• Detailed medication review.
• Assess menstrual/sexual history, libido, and systemic symptoms.
• Breast exam – look for masses, skin changes, nipple inversion, or signs of infection.

Laboratory Tests

• Serum prolactin level: First step; >20 ng/mL (women) or >15 ng/mL (men) is considered elevated.
• Thyroid function tests (TSH, free T4): Detect hypothyroidism.
• Pregnancy test: Rule out lactation from pregnancy.
• Renal and liver panels: Chronic disease can affect hormone clearance.

Imaging

• Magnetic Resonance Imaging (MRI) of the pituitary: Gold standard for adenomas >5 mm.
• Breast ultrasound or mammography: Indicated for unilateral, bloody, or suspicious discharge, especially in women >30 years.
• Chest X‑ray: Occasionally used if sarcoidosis or pulmonary disease is suspected.

Special Procedures

• Ductal cannulation and cytology: Fluid is collected and examined for malignant cells when discharge is bloody or serous.
• Endocrine stimulation tests: Rarely, TRH or dopamine agonist challenge may clarify pituitary function.

Treatment Options

Treatment is directed at the root cause; many cases resolve spontaneously once the trigger is removed.

Medication‑Based Therapies

• Dopamine agonists (first‑line):
  • Cabergoline – 0.25‑0.5 mg weekly; high efficacy, low side‑effects.
  • Bromocriptine – 2.5‑5 mg daily; useful if cabergoline unavailable.
  Both suppress prolactin production and often shrink prolactinomas (<10 % of patients need surgery) [Cleveland Clinic].
• Thyroid hormone replacement: Levothyroxine for hypothyroidism normalizes prolactin.
• Medication review: Discontinuation or substitution of offending drugs under physician guidance.

Surgical and Interventional Options

• Transsphenoidal pituitary surgery: Reserved for large, drug‑resistant prolactinomas or those causing visual field loss.
• Duct excision (microdochectomy): Considered for persistent unilateral bloody discharge when imaging is negative.
• Laser or radiofrequency ablation: Emerging minimally invasive techniques for select ductal lesions.

Lifestyle & Supportive Measures

• Wear loose, breathable bras to avoid nipple irritation.
• Limit nipple stimulation (e.g., avoid frequent breast self‑exams that provoke discharge).
• Stress‑reduction techniques: yoga, mindfulness, regular exercise.
• Maintain a healthy weight to modulate estrogen and prolactin levels.

Living with Nipple Discharge (Galactorrhea)

Practical Daily Management

• Record the discharge: Note color, volume, timing, and any associated symptoms to share with your clinician.
• Hygiene: Gently clean the area with mild soap and water; avoid harsh chemicals that can irritate skin.
• Clothing: Choose cotton fabrics and avoid tight straps that can compress the breast.
• Medication adherence: Take dopamine agonists exactly as prescribed; missed doses can cause rebound prolactin spikes.
• Follow‑up schedule: Typically every 3–6 months for prolactin level checks and imaging until stable.
• Emotional support: Galactorrhea can be distressing; counseling or support groups (e.g., Hormone Health Network) can be helpful.

Impact on Sexual and Reproductive Health

Women experiencing galactorrhea often have menstrual disturbances or infertility. Consulting a reproductive endocrinologist can aid in planning pregnancy, as dopamine agonists are generally safe in early pregnancy but should be reviewed.

Prevention

• Medication vigilance: Discuss potential prolactin‑raising side effects before starting new drugs.
• Manage thyroid health: Regular TSH screening if you have a family history of thyroid disease.
• Breast health: Avoid chronic friction from ill‑fitting bras; treat skin conditions promptly.
• Healthy lifestyle: Balanced diet, regular exercise, and weight control reduce estrogen excess.
• Stress management: Chronic stress may elevate prolactin; incorporate relaxation strategies.

Complications

If left untreated, galactorrhea itself is usually benign, but the underlying condition can lead to serious outcomes:

• Pituitary macroadenoma: May compress the optic chiasm → visual field loss.
• Infertility: Persistent hyperprolactinemia suppresses GnRH, disrupting ovulation.
• Bone loss: Chronic hypogonadism from high prolactin can reduce estrogen/testosterone, increasing osteoporosis risk.
• Breast pathology: Persistent unilateral or bloody discharge warrants evaluation for cancer; delays can affect prognosis.

When to Seek Emergency Care

---

Sources: Mayo Clinic, Cleveland Clinic, National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), peer‑reviewed endocrinology journals (e.g., The Journal of Clinical Endocrinology & Metabolism 2022).

```